CSL (ASX:CSL; USOTC:CSLLY), a global biopharma leader, today broke ground for the expansion of its state-of-the-art ...

Australia’s CSL has opened the first phase of a $170 million plasma products plant that will boost production for the U.S. and Europe as well as Asia-Pacific markets. CSL today said the new facility ...

Gov. Pritzker announced that global biotherapeutics firm CSL will invest nearly $1.5 billion to construct a new manufacturing ...

After teasing a plasma-based manufacturing expansion in the U.S. late last year, CSL is putting in the work and firming up details behind the $1.5-billion project.  | On Monday, CSL broke ground on an ...

Illinois Gov. JB Pritzker on Monday announced a $1.5 billion investment from biotherapeutics company CSL for a new plasma therapy manufacturing plant in Kanakee.

The Kanakee project builds on the biopharma company’s efforts to increase its U.S. footprint, where it has already spent more ...